Who was studied, and how
Four numbers in the abstract
Where each one falls
Only readable comparisons vote
Where it lands on the map
What it changes
Among 23 other studies
195people with type 2 diabetes, in this paper
The trial randomly assignedassigned by chance
liraglutide alone
placebo
Probably lowered postprandial glucose response−7.00
randomisedThe trial randomly assignedassigned by chance
combination of exercise and liraglutide
placebo
Probably lowered postprandial glucose response−9.00
Probably raised beta cell function+49.0
Probably lowered glucagon response−18.0
randomisedthe abstract, start to end
… postprandial glucose response by -7% (95% CI: -12% to -1%; p = …
… postprandial glucose response by -9% (95% CI: -14% to -3%; p = 0.002), improved beta cell function by 49% (95% CI: 16% to 93%; p = 0.002), and decreased glucagon response by -18% (95% CI: -34% to -3%; p = …
← favours treatmentfavours comparator →
could be chancePostprandial glucose responseliraglutide alone vs placebo
−7−12.0 to −1.00
Postprandial glucose responsecombination of exercise and liraglutide vs placebo
−9−14.0 to −3.00
Beta cell functioncombination of exercise and liraglutide vs placebo
4916.0–93.0
Glucagon responsecombination of exercise and liraglutide vs placebo
−18−34.0 to −3.00
GLP-1 receptor agonistsDiet, exercise & lifestyleGlycemic control
GLP-1 receptor agonists × glycemic controlhelps?replicated
unlikelylikely
0.900.90 without it
Diet, exercise & lifestyle × glycemic controlhelps?replicated
unlikelylikely
0.990.50 without it
← favours comparatorfavours treatment →
1 / 7